Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.41 -0.51 (-17.29%)
As of: Oct 2, 2026 · 10:57 AM EDT

Foghorn Therapeutics (FHTX) Other Non Operating Income (2019 - 2026)

Updated

Foghorn Therapeutics (FHTX) reported Other Non Operating Income of $5,000 for Q2 2026, down 99.4% from $852,000 a year earlier.

Analysis

Foghorn Therapeutics (FHTX) Other Non Operating Income (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Foghorn Therapeutics' Other Non Operating Income came in at $1.08 million, down 77.8% year-over-year; for FY2025, it came in at $3.36 million, down 19.3% from FY2024.

  • Other Non Operating Income has a five-year compound annual growth rate of 27.4% (FY2020 to FY2025).
  • By year, Other Non Operating Income came in at $4.16 million in FY2024 (+47.1%), $2.83 million in FY2023 (+9.7%), $2.58 million in FY2022 (+3.4%) and $2.49 million in FY2021 (+149.2%).
  • Five-year quarterly Other Non Operating Income spans a low of -$44,000 in Q1 2026 and a high of $1.41 million in Q4 2024.
  • Year over year, Other Non Operating Income gained in four of the last seven quarters, with growth averaging 8.8%.
  • The high point for year-over-year Other Non Operating Income in five years was Q4 2024 (growth of 107.4%); the low point was Q2 2026 (a decline of 99.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$44,000 (Q1 2026), $502,000 (Q4 2025) and $620,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Foghorn Therapeutics 209.61 Mn -116.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,000.00
Mar 31, 2026 -44,000.00
Dec 31, 2025 502,000.00
Sep 30, 2025 620,000.00
Jun 30, 2025 852,000.00
Mar 31, 2025 1.39 Mn
Dec 31, 2024 1.41 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 783,000.00
Mar 31, 2024 739,000.00
Dec 31, 2023 678,000.00
Sep 30, 2023 721,000.00
Jun 30, 2023 712,000.00
Mar 31, 2023 720,000.00
Dec 31, 2022 624,000.00
Sep 30, 2022 651,000.00
Jun 30, 2022 650,000.00
Mar 31, 2022 655,000.00
Dec 31, 2021 539,000.00
Sep 30, 2021 680,000.00
API Access

Foghorn Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=FHTX&period=max&api_key=YOUR_API_KEY